Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Berchuck

Showing results (81-90 of 372) with videos related to

Pageof 38
Sort By:
Gynecologic Oncology|May 3, 2005
Transforming growth factor beta receptor I polyalanine repeat polymorphism does not increase ovarian cancer riskMonique A Spillman, Joellen M Schildkraut, Susan Halabi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2005
Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancerJaniel M Cragun, Laura J Havrilesky, Brian Calingaert, et al.
Gynecologic Oncology|September 22, 2009
Association between the N-terminally truncated (DeltaN) p63alpha (DeltaNp63alpha) isoform and debulking status, VEGF expression and progression-free survival in previously untreated, advanced stage epithelial ovarian cancer: A Gynecologic Oncology Group studyElizabeth L Jewell, Kathleen M Darcy, Alan Hutson, et al.
Gynecologic Oncology|January 13, 2009
Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group studyJennifer M Rubatt, Kathleen M Darcy, Alan Hutson, et al.
Familial Cancer|November 21, 2016
The hereditary nature of small cell carcinoma of the ovary, hypercalcemic type: two new familial casesLeora Witkowski, Nancy Donini, Rebecca Byler-Dann, et al.
American Journal of Obstetrics and Gynecology|April 26, 2011
Adverse events associated with laparoscopy vs laparotomy in the treatment of endometrial cancerJason C Barnett, Laura J Havrilesky, Amy E Bondurant, et al.
Gynecologic Oncology|January 13, 2006
Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histologyChristopher V Lutman, Laura J Havrilesky, Janiel M Cragun, et al.
Gynecologic Oncology|October 4, 2006
The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancerLaura J Havrilesky, Janiel M Cragun, Brian Calingaert, et al.
Fertility and Sterility|October 20, 2015
Evidence of a genetic link between endometriosis and ovarian cancerAlice W Lee, Claire Templeman, Douglas A Stram, et al.
The American Journal of Surgical Pathology|December 13, 2012
BRCA1 immunohistochemistry in a molecularly characterized cohort of ovarian high-grade serous carcinomasKaruna Garg, Douglas A Levine, Narciso Olvera, et al.
Pageof 38

Showing results (81-90 of 372) with videos related to

Sort By:
Pageof 38
Gynecologic Oncology|May 3, 2005
Transforming growth factor beta receptor I polyalanine repeat polymorphism does not increase ovarian cancer riskMonique A Spillman, Joellen M Schildkraut, Susan Halabi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2005
Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancerJaniel M Cragun, Laura J Havrilesky, Brian Calingaert, et al.
Gynecologic Oncology|September 22, 2009
Association between the N-terminally truncated (DeltaN) p63alpha (DeltaNp63alpha) isoform and debulking status, VEGF expression and progression-free survival in previously untreated, advanced stage epithelial ovarian cancer: A Gynecologic Oncology Group studyElizabeth L Jewell, Kathleen M Darcy, Alan Hutson, et al.
Gynecologic Oncology|January 13, 2009
Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group studyJennifer M Rubatt, Kathleen M Darcy, Alan Hutson, et al.
Familial Cancer|November 21, 2016
The hereditary nature of small cell carcinoma of the ovary, hypercalcemic type: two new familial casesLeora Witkowski, Nancy Donini, Rebecca Byler-Dann, et al.
American Journal of Obstetrics and Gynecology|April 26, 2011
Adverse events associated with laparoscopy vs laparotomy in the treatment of endometrial cancerJason C Barnett, Laura J Havrilesky, Amy E Bondurant, et al.
Gynecologic Oncology|January 13, 2006
Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histologyChristopher V Lutman, Laura J Havrilesky, Janiel M Cragun, et al.
Gynecologic Oncology|October 4, 2006
The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancerLaura J Havrilesky, Janiel M Cragun, Brian Calingaert, et al.
Fertility and Sterility|October 20, 2015
Evidence of a genetic link between endometriosis and ovarian cancerAlice W Lee, Claire Templeman, Douglas A Stram, et al.
The American Journal of Surgical Pathology|December 13, 2012
BRCA1 immunohistochemistry in a molecularly characterized cohort of ovarian high-grade serous carcinomasKaruna Garg, Douglas A Levine, Narciso Olvera, et al.
Pageof 38